Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2013, Article ID 865032, 4 pages
http://dx.doi.org/10.1155/2013/865032
Case Report

PET/CT Imaging in Oncology: Exceptions That Prove the Rule

1Nuclear Medicine Unit, Department of Advanced Technology, Azienda Ospedaliera Santa Maria Nuova, IRCCS, Viale Risorgimento 80, 42123 Reggio Emilia, Italy
2Pulmonology Unit, Department of Cardiology, Thoracic and Vascular Surgery and Critical Care Medicine, Azienda Ospedaliera Santa Maria Nuova, IRCCS, Viale Risorgimento 80, 42123 Reggio Emilia, Italy

Received 22 November 2012; Accepted 31 December 2012

Academic Editors: J. Itami, M. Ryberg, and G. P. Vandoros

Copyright © 2013 M. Casali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Gordin, M. Daitzchman, I. Doweck et al., “Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management,” Laryngoscope, vol. 116, no. 2, pp. 273–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Almuhaideb, N. Papathanasiou, and J. Bomanji, “18F-FDG PET/CT imaging in oncology,” Annals of Saudi Medicine, vol. 31, no. 1, pp. 3–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Basely, S. Bonnel, P. Maszelin, P. Verdalle, E. Bussy, and J. P. De Jaureguiberry, “A rare presentation of metastatic renal clear cell carcinoma to the tongue seen on FDG PET,” Clinical Nuclear Medicine, vol. 34, no. 9, pp. 566–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Bouchelouche and P. Oehr, “Recent developments in urologic oncology: positron emission tomography molecular imaging,” Current Opinion in Oncology, vol. 20, no. 3, pp. 321–326, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. A. Y. Chu, A. Kositwattanarerk, D. J. Lee et al., “Fdg pet with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma,” Radiographics, vol. 30, no. 5, pp. 1353–1372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Balogova, V. Huchet, K. Kerrou et al., “. Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose,” Nuclear Medicine Communications, vol. 31, no. 5, pp. 389–397, 2010. View at Google Scholar
  7. Y. M. Sung, K. S. Lee, B. T. Kim et al., “Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT2005,” European Radiology, vol. 15, no. 10, pp. 2075–2078.
  8. K. Nakatani, Y. Nakamoto, T. Saga, T. Higashi, and K. Togashi, “The potential clinical value of FDG-PET for recurrent renal cell carcinoma,” European Journal of Radiology, vol. 79, no. 1, pp. 29–35, 2011. View at Publisher · View at Google Scholar · View at Scopus